Cost-effectiveness of direct antiviral agents for hepatitis c virus infection and a combined intervention of syringe access and medication-assisted therapy for opioid use disorders in an injection drug use population
Elizabeth R. Stevens, Kimberly A. Nucifora, Holly Hagan, Ashly E. Jordan, Jennifer Uyei, Bilal Khan, Kirk Dombrowski, Don des Jarlais, R. Scott Braithwaite
Dive into the research topics of 'Cost-effectiveness of direct antiviral agents for hepatitis c virus infection and a combined intervention of syringe access and medication-assisted therapy for opioid use disorders in an injection drug use population'. Together they form a unique fingerprint.